Author Affiliation: Section of Female Pelvic Medicine and Reconstructive Surgery, MedStar Washington Hospital Center, Departments of Obstetrics and Gynecology and Urology, Georgetown University School of Medicine, Washington, DC.
Pelvic floor disorders, including pelvic organ prolapse, urinary incontinence, fecal incontinence, and other sensory disorders of the gastrointestinal and genitourinary tract, are common with nearly 1 in 4 US women having at least 1 pelvic floor condition.1 In this issue of JAMA, Nygaard and colleagues2 present findings from the extended Colpopexy and Urinary Reduction Efforts (extended CARE) trial. The original CARE trial3 was a double-blind randomized trial of 322 women mostly with advanced (stage 3-4) prolapse and without stress incontinence symptoms undergoing an open abdominal synthetic mesh sacrocolpopexy procedure either with or without a urethropexy for prevention of stress urinary incontinence.
Iglesia CB. Pelvic Organ Prolapse SurgeryLong-term Outcomes and Implications for Shared Decision Making. JAMA. 2013;309(19):2045-2046. doi:10.1001/jama.2013.5528